Results 11 to 20 of about 59,855 (258)

Tardive dyskinesia [PDF]

open access: yesActa Psychiatrica Scandinavica, 1988
ABSTRACT— Tardive dyskinesia (TD) is a syndrome of involuntary movements that develops in predisposed individuals during neuroleptic drug treatment, with an average prevalence of 15%. Neuroleptic (antidopaminergic) drugs are the predominant etiological factor.
J Gerlach, D E Casey, D E Casey
exaly   +7 more sources

Tardive dyskinesia

open access: yesConsilium Medicum, 2021
Tardive dyskinesia is a group of hyperkinetic and hypokinetic movement disorders, following the administration of dopamine receptor-blocking drugs. The severity of these syndromes varies from soft forms to the development of life-degrading situations ...
Violetta A. Tolmacheva
doaj   +2 more sources

The use of clozapine and clonazepam co-administration in the treatment of a severe tardive dyskinesia: A case report [PDF]

open access: goldSAGE Open Medical Case Reports, 2019
This is a case report of a patient who was treated with clozapine and clonazepam after he developed neuroleptic-induced tardive dyskinesia following treatment for schizophrenia.
Kibrom Haile, Halima Umer
doaj   +2 more sources

Refractory tardive dyskinesia in the critical care setting: A case report of successful use of phenobarbital [PDF]

open access: yesSAGE Open Medical Case Reports
Tardive dyskinesia is a hyperkinetic movement disorder most often induced by chronic antipsychotic use. It can be challenging to treat, particularly when symptoms persist despite standard therapies such as vesicular monoamine transporter 2 inhibitors. We
Abdelrahman S. Abdalla   +4 more
doaj   +2 more sources

Paliperidone ER-induced tardive dyskinesia

open access: greenPsychiatry and Clinical Psychopharmacology, 2021
The evidence suggests a lower tardive dyskinesia risk associated with atypical antipsychotics. We present two adult female cases with tardive dyskinesia.
Omer Yanartas   +4 more
doaj   +3 more sources

Likelihood of mechanistic roles for dopaminergic, serotonergic and glutamatergic receptors in tardive dyskinesia: A comparison of genetic variants in two independent patient populations

open access: yesSAGE Open Medicine, 2016
Objectives: An established theory for the pathogenesis of tardive dyskinesia is disturbed dopaminergic receptor sensitivity and/or dopaminergic intracellular signaling.
Svetlana A Ivanova   +12 more
doaj   +2 more sources

Co‐Expression of Tardive Dyskinesia and Drug‐Induced Parkinsonism in Rats Chronically Treated With Haloperidol [PDF]

open access: yesNeuropsychopharmacology Reports
Aim We aimed to create a rat model of drug‐induced parkinsonism and tardive dyskinesia by chronic administration of haloperidol and examine the expression of direct and indirect pathway markers in the striatum of the model rats.
Iku Kinoshita   +7 more
doaj   +2 more sources

Patient and physician perceptions of the burden of tardive dyskinesia: an international survey [PDF]

open access: diamondBMJ Neurol Open
Craig Chepke   +10 more
openalex   +2 more sources

Pathophysiology, prognosis and treatment of tardive dyskinesia

open access: yesTherapeutic Advances in Psychopharmacology, 2022
Tardive dyskinesia (TD), a movement disorder associated with antipsychotics, most frequently affects the lower face and jaw muscles, but can also affect walking, breathing and use of the hands and limbs.
H. Takeuchi, Yasuhiro Mori, Y. Tsutsumi
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy